Literature DB >> 25352352

Attention and CERAD test performances in cognitively impaired elderly subjects.

S Verhülsdonk1, F Hellen, B Höft, T Supprian, C Lange-Asschenfeldt.   

Abstract

OBJECTIVES: Attention plays a fundamental role in cognitive performance and is closely interrelated with all major cognitive domains. In this retrospective study, we correlated different measures of attention with standard cognitive parameters in 85 cognitively impaired elderly individuals presenting with cognitive complaints to a memory clinic.
MATERIALS AND METHODS: Z-scores of all relevant cognitive parameters of a extended Consortium to Establish a Registry for Alzheimer's disease (CERAD-Plus) neuropsychological battery were correlated with tonic and phasic alertness, inhibition, and divided attention, assessed by a computerized test battery of attention. The pooled sample consisted of 36 patients with the diagnosis of mild AD, 30 patients with mild cognitive impairment, and 19 patients with major depressive disorder.
RESULTS: Subjects of all diagnostic groups exhibited normal results in all subtests of attention. Reaction times of neither the tonic nor the phasic alertness task were correlated with any parameter of memory and global cognition. However, significant correlations were obtained between reaction times in the alertness tasks and the trail-making tests. Omissions in the divided attention task yielded the strongest correlations with deficits in cognitive performance, particularly in the verbal learning tasks, the Boston naming test, and the trail-making tests.
CONCLUSIONS: Our data demonstrate the relative independency of the CERAD-Plus on the variability of attention and particularly alertness suggesting its robustness in psychiatric memory clinic settings. Moreover, CERAD-Plus subtests correlated considerably with failure rates in divided attention, suggesting that impairment in divided attention tasks may be early markers of cognitive impairment.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Alzheimer's disease; depression; mild cognitive impairment; neuropsychology

Mesh:

Year:  2014        PMID: 25352352     DOI: 10.1111/ane.12346

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  6 in total

1.  Frequency of dementia syndromes with a potentially treatable cause in geriatric in-patients: analysis of a 1-year interval.

Authors:  Marija Djukic; Dirk Wedekind; Almuth Franz; Melanie Gremke; Roland Nau
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-02-26       Impact factor: 5.270

Review 2.  Sleep and Attention in Alzheimer's Disease.

Authors:  Mirna Hennawy; Solomon Sabovich; Celina S Liu; Nathan Herrmann; Krista L Lanctôt
Journal:  Yale J Biol Med       Date:  2019-03-25

3.  Cognitive impairment in patients with Neuro-Sjögren.

Authors:  Tabea Seeliger; Lena Jacobsen; Merle Hendel; Lena Bönig; Nils K Kristian Prenzler; Thea Thiele; Diana Ernst; Torsten Witte; Martin Stangel; Bruno Kopp; Thomas Skripuletz
Journal:  Ann Clin Transl Neurol       Date:  2020-07-06       Impact factor: 4.511

Review 4.  microRNA-Based Biomarkers and the Diagnosis of Alzheimer's Disease.

Authors:  Yuhai Zhao; Surjyadipta Bhattacharjee; Prerna Dua; Peter N Alexandrov; Walter J Lukiw
Journal:  Front Neurol       Date:  2015-07-13       Impact factor: 4.003

5.  Anti-microRNAs as Novel Therapeutic Agents in the Clinical Management of Alzheimer's Disease.

Authors:  Yuhai Zhao; Peter N Alexandrov; Walter J Lukiw
Journal:  Front Neurosci       Date:  2016-02-25       Impact factor: 4.677

Review 6.  microRNA-Based Biomarkers in Alzheimer's Disease (AD).

Authors:  Yuhai Zhao; Vivian Jaber; Peter N Alexandrov; Andrea Vergallo; Simone Lista; Harald Hampel; Walter J Lukiw
Journal:  Front Neurosci       Date:  2020-10-30       Impact factor: 4.677

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.